Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nayzilam for Seizure Clusters in Epilepsy
NCT01529034Phase 3Terminated
- Sponsor
- UCB
- Start
- Jul 2012
- Primary completion
- Apr 2017
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 3 trial of midazolam in epilepsy, sponsored by UCB. Started Jul 2012; status: terminated.
02
Drugs
midazolam
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT01529034.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01529034.